Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults with moderate-to-severe atopic dermatitis: Analysis of microbial diversity in ECZTRA 1, a randomized controlled trial.
- DOI
- 10.1016/j.jaad.2022.11.047
- Published
- 2023 Apr
- Container
- Journal of the American Academy of Dermatology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jaad.2022.11.047,
title = {Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults with moderate-to-severe atopic dermatitis: Analysis of microbial diversity in ECZTRA 1, a randomized controlled trial.},
author = {Beck LA and Bieber T and Weidinger S and Tauber M and Saeki H and Irvine AD and Eichenfield LF and Werfel T and Arlert P and Jiang L and Røpke M and Paller AS},
year = {2023},
journal = {Journal of the American Academy of Dermatology},
doi = {10.1016/j.jaad.2022.11.047},
url = {https://doi.org/10.1016/j.jaad.2022.11.047}
}RIS
TY - JOUR TI - Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults with moderate-to-severe atopic dermatitis: Analysis of microbial diversity in ECZTRA 1, a randomized controlled trial. AU - Beck LA AU - Bieber T AU - Weidinger S AU - Tauber M AU - Saeki H AU - Irvine AD AU - Eichenfield LF AU - Werfel T AU - Arlert P AU - Jiang L AU - Røpke M AU - Paller AS PY - 2023 JO - Journal of the American Academy of Dermatology DO - 10.1016/j.jaad.2022.11.047 UR - https://doi.org/10.1016/j.jaad.2022.11.047 ER -
APA
LA, B., T, B., S, W., M, T., H, S., AD, I., LF, E., T, W., P, A., L, J., M, R., & AS, P. (2023). Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults with moderate-to-severe atopic dermatitis: Analysis of microbial diversity in ECZTRA 1, a randomized controlled trial.. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2022.11.047
Source records
- pubmed · retrieved 2026-09-27T08:50:36.795Z